PRO Journal SA-CME activity for September-October, 2019 (Volume 9, Issue 5) provides practitioners with the knowledge needed to prepare for and recover from a natural disaster.

IJROBP Journal SA-CME activity for September 1, 2019 (Volume 105, Issue 1) provides practitioners with information regarding the techniques of intensity-modulated brachytherapy and its clinical applications. 

IJROBP Journal SA-CME activity for August 1, 2019 (Volume 104, Issue 5) provides practitioners with information on how one institution conducted a phase I/II study for cardiac radioablation ventricular tachycardia. Dosimetric details are provided in this study. 

IJROBP Journal SA-CME activity for July 15, 2019 (Volume 104, Issue 4) provides practitioners with knowledge needed to appropriately select patients for stereotactic body radiotherapy and counsel them regarding efficacy and side effects.

PRO Journal SA-CME activity for July-August, 2019 (Volume 9, Issue 4) will help practitioners to identify planning uncertainties and elements required for unambiguous reporting. 

IJROBP Journal SA-CME activity for March 1, 2015 (Volume 91, Issue 3) investigate the efficacy and toxicity of accelerated hypofractionated thoracic radiotherapy combined with concurrent chemotherapy in the treatment of limited-stage small cell lung cancer.

PRO Journal SA-CME activity for March-April, 2019 (Volume 9, Issue 2) provides practitioners with a review of factors influencing efficacy of radiotherapy in pain response of symptomatic bone metastases.  

IJROBP Journal SA-CME activity for July 1, 2019 (Volume 104, Issue 3) provides practitioners with guidelines for best practice of use of imaging in pre-treatment evaluation, treatment choice, RT target volume definition, and RT treatment verification and delivery. 

IJROBP Journal SA-CME activity for June 1, 2019 (Volume 104, Issue 2) provides practitioners with the knowledge needed to assess and critique the quality of a radiomics report.

IJROBP Journal SA-CME activity for May 1, 2019 (Volume 104, Issue 1) provides practitioners with the knowledge needed to selectively treat high risk prostate cancer patients with stereotactic body radiotherapy.

Pages

Subscribe to RSS - Journal Activities